Literature DB >> 17468835

CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients.

Hui Li1, Jin-Pu Yu, Shui Cao, Feng Wei, Peng Zhang, Xiu-Mei An, Zong-Tang Huang, Xiu-Bao Ren.   

Abstract

: CD(4) (+)CD(25) (+) regulatory T cells (Tregs) have been shown to inhibit cytotoxic lymphocytes-mediated immune responses. Cytokine-induced killer (CIK) cells exert high impact on adoptive immunotherapeutic approaches. Therefore, the purpose of this report was to determine the effect of Tregs on CIK cell growth and CIK-induced cytotoxicity for inhibition of tumor growth in vivo as well as in vitro. After depletion of CD(4) (+)CD(25) (+) cells before culture, the proliferation and cytotoxicity of CIK cells, which indicated in bromodeoxyuridine (BrdU) and lactic dehydrogenase (LDH) assays, were significantly increased. Depletion of CD(4) (+)CD(25) (+) cells preculture also enhanced the suppression effect on the lung cancer cells inoculated in experimental animals. Blockage of glucocorticoid-induced tumor necrosis factor receptor (GITR) and transforming growth factor beta1 (TGF-beta1) by antibodies partially abrogated the suppressive effect of CD(4) (+)CD(25) (+) cells on CIK. These results indicated that Tregs could inhibit the antitumor activity of CIK cells. The molecules TGF-beta and GITR may contribute to the suppressive function of CD(4) (+)CD(25) (+) cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17468835     DOI: 10.1007/s10875-007-9076-0

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.542


  17 in total

1.  Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA-4 expression.

Authors:  Brigitte Birebent; Richard Lorho; Hélène Lechartier; Sophie de Guibert; Mehdi Alizadeh; Nicolas Vu; Alain Beauplet; Nelly Robillard; Gilbert Semana
Journal:  Eur J Immunol       Date:  2004-12       Impact factor: 5.532

2.  IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice.

Authors:  Keith L Knutson; Yushe Dang; Hailing Lu; Jason Lukas; Bond Almand; Ekram Gad; Ehizoje Azeke; Mary L Disis
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

3.  CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine.

Authors:  Alberto Comes; Ombretta Rosso; Anna Maria Orengo; Emma Di Carlo; Carlo Sorrentino; Raffaella Meazza; Tiziana Piazza; Barbara Valzasina; Patrizia Nanni; Mario P Colombo; Silvano Ferrini
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

Review 4.  The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer.

Authors:  Khashayarsha Khazaie; Harald von Boehmer
Journal:  Semin Cancer Biol       Date:  2006-01-26       Impact factor: 15.707

5.  CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R.

Authors:  You-Shun Zhang; Fang-Jun Yuan; Guo-Feng Jia; Ji-Fa Zhang; Li-Yi Hu; Ling Huang; Ju Wang; Zong-Qing Dai
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

6.  Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma.

Authors:  Nitya G Chakraborty; Subhasis Chattopadhyay; Shikhar Mehrotra; Arvind Chhabra; Bijay Mukherji
Journal:  Hum Immunol       Date:  2004-08       Impact factor: 2.850

7.  Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

Authors:  I G Schmidt-Wolf; P Lefterova; B A Mehta; L P Fernandez; D Huhn; K G Blume; I L Weissman; R S Negrin
Journal:  Exp Hematol       Date:  1993-12       Impact factor: 3.084

8.  Th1 bias in PBMC induced by multicycles of auto-CIKs infusion in malignant solid tumor patients.

Authors:  Xiubao Ren; Jinpu Yu; Hong Liu; Peng Zhang; Xiumei An; Naining Zhang; Xishan Hao
Journal:  Cancer Biother Radiopharm       Date:  2006-02       Impact factor: 3.099

Review 9.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

Authors:  Shimon Sakaguchi
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

10.  Human CD4+ CD25+ regulatory T cells suppress NKT cell functions.

Authors:  Takeshi Azuma; Tsuyoshi Takahashi; Atsushi Kunisato; Tadaichi Kitamura; Hisamaru Hirai
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  27 in total

Review 1.  Myeloid suppressor cells and immune modulation in lung cancer.

Authors:  Minu K Srivastava; Åsa Andersson; Li Zhu; Marni Harris-White; Jay M Lee; Steven Dubinett; Sherven Sharma
Journal:  Immunotherapy       Date:  2012-03       Impact factor: 4.196

2.  Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma.

Authors:  Hui Liu; Jianyu Li; Fengmei Wang; Yingtang Gao; Ying Luo; Peng Wang; Chenglong Li; Zhengyan Zhu
Journal:  Tumour Biol       Date:  2014-11-24

3.  Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.

Authors:  Giulia Mesiano; Roberta Zini; Giulia Montagner; Nicoletta Bianchi; Rossella Manfredini; Antonella Chillemi; Massimo Aglietta; Giovanni Grignani; Ilaria Lampronti; Erika Fiorino; Fabio Malavasi; Dario Sangiolo; Roberto Gambari; Davide Ferrari
Journal:  Mol Med       Date:  2017-08-09       Impact factor: 6.354

4.  Primitive neuroectodermal tumor of the kidney at the advanced stage: A case series of eight Chinese patients.

Authors:  Qipeng Sun; Bin Miao; Xiangming Lao; Ping Yuan; Jiarong Cai; Hailun Zhan
Journal:  Mol Clin Oncol       Date:  2018-04-19

5.  Cytokine-induced killer cells combined with dendritic cells inhibited liver cancer cells.

Authors:  Qi-Ying Li; Yang Shi; De-Hong Huang; Tao Yang; Jiang-Hong Wang; Guo-He Yan; Hong-Yu Wang; Xian-Jun Tang; Chun-Yan Xiao; Wen-Jun Zhang; Man Zhang; Li Wang; Yi Gong; Wei Yang; Xian-Yu Wu; Ying Xiang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

6.  Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells.

Authors:  Xiang Huang; Yi-Tian Chen; Hai-Zhu Song; Gui-Chun Huang; Long-Bang Chen
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

Review 7.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

8.  Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.

Authors:  Yiting Geng; Hui Wang; Changqing Lu; Qing Li; Bin Xu; Jingting Jiang; Changping Wu
Journal:  Int J Clin Oncol       Date:  2014-05-09       Impact factor: 3.402

9.  Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer.

Authors:  Stefanie Stanzer; Nadia Dandachi; Marija Balic; Margit Resel; Hellmut Samonigg; Thomas Bauernhofer
Journal:  J Clin Immunol       Date:  2007-10-16       Impact factor: 8.317

Review 10.  Clinical studies applying cytokine-induced killer cells for the treatment of renal cell carcinoma.

Authors:  Clara E Jäkel; Stefan Hauser; Sebastian Rogenhofer; Stefan C Müller; P Brossart; Ingo G H Schmidt-Wolf
Journal:  Clin Dev Immunol       Date:  2012-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.